Global health regimes have reversed the role of traditional birth attendants (TBAs) from partners in the fight against maternal and child mortality to barriers to indicator-driven care. In rural Tanzania, widespread fear of government surveillance and punishment for non-compliant individuals and organizations that climaxed during the presidency of the late John Magufuli (2015-2021) put increased pressure on TBAs. To negotiate tensions, TBAs adopted the position that they only escort women to health facilities for birth. We argue that TBAs' insistence on this only both occludes and protects their multiple caring roles and responsibilities in a context of harsher home birth penalties, yet limited efforts to improve systemic shortages in the rural health system. TBAs' performance of "we only escort women" operates both as the sedimentation of policies, a way to resist them, and means to hold space for TBAs in the wake of ambiguous global and national health policies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/maq.12917 | DOI Listing |
JACC Case Rep
March 2025
Department of Cardiology, Poonia Hospital, Sirsa, Haryana, India.
Spreading epidemic of atherosclerotic coronary artery disease coupled with huge technical advancement, has led to steep rise in percutaneous coronary interventions. The coronary intervention might be complicated with catheter-induced coronary artery dissection and intramural hematoma. It usually spread antegradely along the course of coronary artery but occasionally retrograde extension into the aorta leads to horrible visual impression.
View Article and Find Full Text PDFCardiol Res
April 2025
Department of Non-Surgical Clinical Sciences, Faculty of Medicine, Wroclaw University of Science and Technology (WUST), Wroclaw, Poland.
Background: Drug-eluting balloons, surface-coated with antiproliferative agents such as sirolimus or paclitaxel, have emerged as an alternative therapeutic option for coronary stenosis. This study evaluated safety and effectiveness of the MOZEC sirolimus-eluting percutaneous transluminal coronary angioplasty (PTCA) balloon dilation catheter (Meril Life Sciences Pvt. Ltd.
View Article and Find Full Text PDFJ Anaesthesiol Clin Pharmacol
January 2025
Department of Cardiac Anaesthesiology, Fortis Escorts Heart Institute and Research Centre, New Delhi, India.
Drug Discov Ther
March 2025
Departments of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
This study aimed to investigate in detail the efficacy of switching from etanercept reference product (RP) to etanercept biosimilar in patients with rheumatoid arthritis (RA) under real-world clinical conditions using clinical indices and musculoskeletal ultrasound (MSUS). This interventional, multicenter, open-label, single-arm clinical trial involved 24- or 52-week follow-up. This study enrolled patients with RA who had been treated with etanercept-RP for ≥ 24 weeks, achieved clinical low disease activity (LDA) or remission, and switched from etanercept-RP to etanercept biosimilar.
View Article and Find Full Text PDFHealth Soc Care Deliv Res
February 2025
School of Health Sciences, University of Surrey, Guildford, UK.
Background: The increasing size of the ageing English prison population means that non-communicable diseases such as cancer are being more commonly diagnosed in this setting. Little research has so far considered the incidence of cancer in the English prison population, the treatment patients receive when they are diagnosed in a prison setting, their care costs and outcomes or their experiences of care compared with those of people diagnosed in the general population. This is the first mixed-methods study that has been designed to investigate these issues in order to inform recommendations for cancer practice, policy and research in English prisons.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!